1. Home
  2. Companies
  3. Celldex Therapeutics
  4. Financial Ratios
  5. DSO Ratio
Celldex Therapeutics logo
Celldex Therapeutics CLDX
$ 28.62 -4.38%

Quarterly report 2026-Q1
added 05-07-2026

report update icon

Celldex Therapeutics DSO Ratio 2011-2026 | CLDX

Annual DSO Ratio Celldex Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
321 86.5 78.9 40.2 77.5 69.3 104 121 53.8 96 64.6 43.5 43.4 1.43 6.7 1.26 - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
321 1.26 75.5

Quarterly DSO Ratio Celldex Therapeutics

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
973 - 72.1 116 - 34.1 76.8 1.55 K - 11.1 244 78.4 - 32.1 95.2 109 - 207 30.5 242 43.4 246 697 47.1 104 170 130 134 164 307 104 56.5 49.6 43.7 44.8 109 86.9 73.3 117 96.4 49.5 86.3 40.6 131 26.4 35.4 65.8 100 72 45.5 460 10.1 1.1 1.29 2 4.01 6.38 6.56 7.95 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.55 K 1.1 145

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
 		2.94 K - 5743.5 % $ 69.7 M canadaCanada
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
 		29 - 1.35 % $ 17.8 M chinaChina
Coherus BioSciences Coherus BioSciences
CHRS
 		559 $ 1.45 -7.94 % $ 170 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
 		186 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
 		271 - - $ 866 M chinaChina
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
 		60.8 - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		84.7 - - $ 40.3 B usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
 		400 $ 2.1 -5.41 % $ 196 M israelIsrael
Alpine Immune Sciences Alpine Immune Sciences
ALPN
 		1.73 - - $ 2.17 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		13.6 - - $ 867 M germanyGermany
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		2.75 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		204 - -18.52 % $ 27.3 M britainBritain
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
 		1.1 K $ 51.84 -8.97 % $ 4.66 B schweizSchweiz
Affimed N.V. Affimed N.V.
AFMD
 		31.4 - -34.95 % $ 21.5 M germanyGermany
Celyad Oncology SA Celyad Oncology SA
CYAD
 		64.4 - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
 		103 - -7.31 % $ 87 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
 		47.6 - - $ 344 M usaUSA
IMV IMV
IMV
 		2.16 K - - $ 13.1 M canadaCanada
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		61.7 - - $ 7.46 M israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		3.66 K - -4.36 % $ 27 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
 		76.5 $ 14.48 -2.1 % $ 208 M usaUSA
Advaxis Advaxis
ADXS
 		3.28 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		146 - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		216 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		126 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		17.9 - 1.93 % $ 17.4 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		28.1 $ 3.09 -2.22 % $ 5.09 M israelIsrael
Aptinyx Aptinyx
APTX
 		46.9 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		14.7 - -0.23 % $ 916 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		106 $ 21.23 -3.28 % $ 2.7 B usaUSA